Only palliative treatment has been proposed
You have been offered only systemic chemotherapy and no one has assessed whether cytoreductive surgery is viable in your case.
CC-0 radical surgery with ERAS protocols at Centro Medico Teknon. The team assesses your case from scratch, even if you have been told surgery is not possible.
If you recognise any of these scenarios, the team can review your case from scratch and give you an honest assessment of surgical possibilities.
You have been offered only systemic chemotherapy and no one has assessed whether cytoreductive surgery is viable in your case.
You have extensive peritoneal disease and another team considered it inoperable. You want a high-volume centre to perform its own independent assessment.
You have been told the Peritoneal Cancer Index makes surgery unfeasible. Resectability limits vary significantly with team experience.
You have had a peritoneal relapse after a first intervention and want to know whether a second cytoreduction is indicated.
You have received the diagnosis and do not yet have a surgical roadmap. You want a first opinion from a specialist team.
No one has assessed whether your cytoreduction could be combined with HIPEC to improve oncological outcomes.
CRS is not a standard procedure. Accumulated experience, achievable radicality, and postoperative protocols determine outcomes.
The team pursues total removal of all visible macroscopic disease (complete cytoreduction, CC-0). This is the strongest prognostic factor after CRS.
When necessary, CRS includes resection of portions of the peritoneum, bowel, spleen, gallbladder, or other affected organs. Radicality is the objective, with the least possible functional impact.
In selected patients, immediately after cytoreduction, HIPEC can be added: perfusion of heated chemotherapy into the abdominal cavity to eliminate microscopic residual disease.
Enhanced recovery (ERAS) reduces complications and shortens hospital stay. Every case is decided by a committee including surgeons, medical oncologist, radiologist, and pathologist.
The surgeon who assesses your case is the same surgeon who operates. The team includes specialists specifically in the colorectal component of peritoneal disease.
Surgical Oncologist · International reference in peritoneal carcinomatosis
View profilePrincipal investigator of the PRODIGE-7 trial. Over 500 CRS procedures support the ability to tackle high-complexity cases. Trained at the Institut Gustave Roussy.
Surgical Oncologist · Co-director of the peritoneal unit
View profileThe key is meticulous candidate selection and achieving CC-0 radicality in every procedure. Extensive experience in peritoneal surface oncology across all primary tumour types.
Colorectal Surgeon · Specialist in the colorectal component of CRS
View profilePrecision in the colorectal component of cytoreduction is decisive for patient functionality after surgery. Two robotic fellowships and ESCP Committee member.
Complete the form and the coordinator tells you exactly what documentation is needed to assess your case.
Surgeons, medical oncologist, and radiologist analyse your case in a multidisciplinary session and determine whether there is a surgical indication.
The coordinator explains the committee's assessment: whether CRS is indicated, whether HIPEC is considered, and what the next step is.
The assessment does not commit you to anything. If you decide to have surgery, we organise everything. If not, we provide the clinical information in writing.
The team's historic base in Barcelona, at the leading international private hospital. Passeig de Carlos III, 60-66, 08017 Barcelona.
Equipped with specific instruments for peritonectomies, HIPEC perfusion systems, and continuous intraoperative monitoring.
Intensive care unit experienced in postoperative follow-up of long-duration oncological surgeries.
All rooms are private, with the option of a companion throughout the stay.
Metro (L6 La Bonanova), commuter rail (FGC Sarria), taxi, own car park. 20 minutes from Barcelona El Prat Airport. More about Teknon.
(Original reviews in Spanish, authentic patient testimonials)
A mi padre en la Salud publica le daban un ano de vida maximo. Solo le daban un tratamiento de quimio y ninguna esperanza, decian que era imposible, que no se podia hacer nada por el. Tenia varios tumores dentro del saco peritoneal con metastasis. Un ano y medio despues esta limpio, totalmente curado. En el ultimo PET (prueba de imagen) ha salido limpio. Estamos muy contentos. Gracias al Dr. Torrent y su equipo. GRACIAS.
Soy una paciente de 63 anos. Me detectan un cancer de la glandula suprarrenal y me dicen que no hay nada que hacer. Busco una segunda opinion y me hablan del equipo Quenet Torrent, especialistas en operaciones complejas. El doctor Torrent, desde el primer momento, me dice que pueden operarme. Me intervienen y me extraen una gran masa tumoral. Estuve una semana en la UCI y un mes en planta. No hay que arrojar la toalla. Soy feliz por haber encontrado a estos profesionales que me han devuelto la vida. Gracias.
Excelentes profesionales, en especial el Dr. Torrent, pendiente en todo momento de la paciente (mi esposa), operada de pseudomixoma peritoneal. Nos ayudaron con todas nuestras necesidades puesto que veniamos de fuera de Barcelona. Gracias Elisabeth. Estamos muy agradecidos al Quenet Torrent Institute, gracias por todo.
Direct answers before contacting the team.
It is performed by Dr. Francois Quenet, Dr. Juan Jose Torrent, Prof. Luis Gonzalez Bayon and, for the colorectal component, Dr. Patricia Tejedor. The team has more than 500 cytoreduction procedures behind it and operates at Centro Medico Teknon in Barcelona. It is the same team that operates at the Madrid site.
CC-0 means that no visible tumour deposit is left in the abdomen at the end of surgery. It is the factor with most influence on the long-term oncological outcome, ahead of how extensive the disease was to begin with. The team always pursues CC-0 when the anatomy allows it at an acceptable risk.
No. Adding HIPEC depends on the tumour origin, the histology, the extent measured by the PCI and the treatment already received. In some cases cytoreduction alone is the correct indication, and in others PIPAC is considered instead. The decision is made at a multidisciplinary meeting, not by automatic protocol.
Between 4 and 10 hours, depending on the extent of disease and the number of resections and peritonectomies required. It is performed in a single operative session under general anaesthesia. When HIPEC is added, the perfusion takes a further 30 to 90 minutes within the same operation.
The average stay is 7 to 14 days at Centro Medico Teknon. The first days may require intensive care, depending on the magnitude of the surgery. The ERAS enhanced recovery protocols the team applies, with early mobilisation and early nutrition, shorten that time and reduce complications.
Yes. A significant proportion of the patients we treat were declared inoperable at another centre. The committee assesses every case from scratch, with up-to-date imaging and criteria based on the team's own volume. Sometimes the conclusion is the same, and then we explain why and what alternatives exist.
Yes. Centro Medico Teknon has agreements with the main private health insurers in Spain. Cover for this type of surgery depends on each policy and on prior authorisation, so the coordinator reviews your case and explains what your insurer covers and what would fall outside before you take any step.
Fill in the form on this page or call +34 660 658 276. The coordinator will contact you within 24 hours and tell you which reports and imaging studies to send. With that documentation, the committee assesses the case and proposes a concrete plan.
Send your imaging and reports. The team will review your case within 48 hours and give you an expert assessment of resectability.
Completa el formulario y agenda tu cita para hablar directamente con el cirujano.